The Asia-Pacific Ophthalmology Device Market which is a USD 6.14 billion market in 2018 is poised to reach USD 8.42 Billion by 2023 with an impressive CAGR of 6.5% in the forecasted period. The ophthalmology device market is one of the key growth area in the medical device industry with a rising demand for better quality healthcare services to improve millions of lives. Ophthalmic devices primarily include glaucoma, refractive and cataract surgical devices among others. With rising awareness and fast approvals, the growth is most likely to sustain the coming years.
Ophthalmology devices encompasses surgical devices which are mainly used in treating infections and conditions relating to eye. The usage of ophthalmology devices in surgeries has made it possible for decreasing treatment time drastically, while providing better eye care protection. These devices are also proved to make the process of treating eyes more convenient for ophthalmologists and patients.
Owing to its advantages over its counter parts, Ophthalmology device market is currently among the faster growing segments in the medical device market. The surge in demand is mainly attributed to the technological innovations, growing prevalence of eye diseases and aging population. The market is also aided by a host of other factors that include rising expenditure by governments and people on healthcare, increasing funding from government and continuous improvements in the field of medicine have all contributed positively to the ophthalmology market. However, there are a few hurdles, the market has to overcome for its healthy growth which include lack of insurances for healthcare in the developing countries, lack of knowledge about diseases like glaucoma and poor infrastructure in healthcare.
The Asia-Pacific ophthalmology device market is studied under various segments based on the disorders, applications and devices. Based on application, the market is categorised as surgery, vision care and diagnostics & monitoring devices. By type of disorders, the market is analysed under Cataract, Vitero retinal, refractor disorder and glaucoma. On the basis of devices, the market is segmented as canaloplasty device and computerised field analyser. Based on geography, Asia-Pacific market is segmented as China, Japan, India, South Korea and Australia.
The leading shareholders of the ophthalmology device market are Bausch and Lomb Inc., Abbott Medical Optics Inc., Alcon Inc., Johnson & Johnson, Carl Zeiss Meditec, Essilor International, Nidek CO Ltd., Hoya Corporation, Topcon Corporation, HAAG-Streit Group, and Ziemer Ophthalmic System.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Application
5.1.1 Diagnostics & Monitoring devices
5.1.2 Surgery Devices
5.1.3 Vision Care Devices
5.2 By Disorders
5.2.1 Cataract
5.2.2 Glaucoma
5.2.3 Refractor disorders
5.2.4 Vitreo retinal disorder
5.3 By Device
5.3.1 Canaloplasty devices
5.3.2 Computerized Field Analyser
6. Geographical Analysis
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Alcon Inc.,
8.3 Abbott Medical Optics Inc.
8.4 Essilor International
8.5 Bausch and Lomb Inc.
8.6 Topcon Corporation
8.7 Nidek CO Ltd.
8.8 HAAG-Streit Group
8.9 Carl Zeiss Meditec
8.10 Hoya Corporation
8.11 Ziemer Ophthalmic System
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
